|Ms. Regina E. Groves||Chief Exec. Officer & Director||N/A||N/A||60|
|Mr. Robert B. Stockman||Co-Founder and Director||N/A||N/A||64|
|Mr. Richard M. Kimes||Sr. VP of Operations||319.02k||N/A||56|
|Mr. Jeffrey A. Anderson||Sr. VP of Clinical and Regulatory Affairs||N/A||N/A||51|
|Ms. Brandi L. Roberts CPA, M.B.A.||CFO, Company Sec. & Sr. VP||N/A||N/A||44|
REVA Medical, Inc., a medical device company, focuses on the commercialization of minimally invasive medical devices for the treatment of conditions in the human body. It is developing Fantom, a drug-eluting bioresorbable stent to treat vascular disease in humans. The company was formerly known as MD3, Inc. and changed its name to REVA Medical, Inc. in March 2002. REVA Medical, Inc. was founded in 1998 and is headquartered in San Diego, California.
REVA Medical, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.